BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

March 27, 2024

https://www.globenewswire.com/news-release/2024/03/27/2853582/0/en/BioCardia-Reports-Fourth-Quarter-and-Full-Year-2023-Business-Highlights-and-Financial-Results.html

SUNNYVALE, Calif., March 27, 2024 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2023 and filed its annual report on Form 10-K with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights with call details below.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.